Anatomical insights and management strategies for haemodynamically significant pressure-restrictive perimembranous ventricular septal defects: Findings from the French nationwide FRANCISCO cohort
Archives of Cardiovascular Diseases · 2025
DOI: 10.1016/j.acvd.2025.02.014 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Archives of Cardiovascular Diseases, 2025. Verfasst von Annabel Sudaka und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric and Adult Congenital Heart Diseases, M3C network for Complex Congenital Heart Disease, Marie Lannelongue Hospital, Paris-Sac…. Hauptthemen laut MEDLINE: Heart Septal Defects, Ventricular, Hemodynamics, Cardiac Catheterization, Cardiac Surgical Procedures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: University Research Committee, Emory University, Federation Francaise de Cardiologie.
Abstract (Originalsprache)
BACKGROUND: Management of haemodynamically significant pressure-restrictive perimembranous ventricular septal defects (pmVSDs) with left ventricular volume overload, but without pulmonary hypertension, is under debate. AIMS: To describe pmVSD characteristics, and factors influencing closure decisions in France. METHODS: FRANCISCO is a French cohort of patients aged>1year with isolated haemodynamically significant pressure-restrictive pmVSDs. Data collected at inclusion were analysed. RESULTS: From 2018-2020, 212 patients from 38 centres were included: mean age 8.8±11.2years; 41% aged 1-2years; 40% aged 3-15years; 19% aged>15years. Mean defect diameter was 6±3mm; 77% had membranous aneurysms, 9% inlet/outlet extension, 3% aortic cusp prolapse and 8% aortic regurgitation. Closure (transcatheter or surgical) occurred in 54 patients (26%). Defect closure rates varied across the 10 major regions in France. Closure was associated with larger defect diameter (odds ratio [OR] 1.5, 95% confidence interval [CI] 1.3-1.7), inlet/outlet extension (OR 3.5, 95% CI 1.4-9.1), greater aneurysm height (OR 1.3, 95% CI 1.1-1.5), aortic regurgitation (OR 4.5, 95% CI 1.6-12.8) and prolapse (OR 8.3, 95% CI 1.6-44.4). In those aged 1-2years, closure was driven by dyspnoea (OR 4.9, 95% CI 1.6-15.2) and defect diameter (OR 1.6, 95% CI 1.2-1.6). In those aged 3-15years, key factors included defect diameter (OR 1.5, 95% CI 1.2-1.9), aortic regurgitation (OR 7.4, 95% CI 1.6-33.8), aneurysm height (OR 1.5, 95% CI 1.1-2.0) and inlet/outlet extension (OR 9.5, 95% CI 2.1-42.8). In those aged>15years, only defect diameter (OR 1.3, 95% CI 1.3-1.8) was predictive of closure. CONCLUSIONS: In France, pmVSD closure in patients aged>1year lacks standardization, with decisions driven by symptoms, anatomical factors and individual centre protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatric and Adult Congenital Heart Diseases, M3C network for Complex Congenital Heart Disease, Marie Lannelongue Hospital, Paris-Saclay University, 92350 Le Plessis-Robinson, France; INSERM UMR_S 999 "…
- Department of Paediatric Cardiology, M3C network for Complex Congenital Heart Disease, Haut-Lévêque University Hospital, 33604 Pessac, France.
- Department of Paediatric Cardiology, La Louvière Hospital, 59800 Lille, France.
- Department of Paediatric Cardiology, M3Cnetwork for Complex Congenital Heart Disease, Children's hospital, Toulouse University Hospital, 31059 Toulouse, France.
- Department of Paediatric Cardiology, M3C network for Complex Congenital Heart Disease, Lille University Hospital, 59000 Lille, France.
- Department of Congenital and Paediatric Cardiology, M3C network for Complex Congenital Heart Disease, Hôpital Universitaire Necker-Enfants Malades, AP-HP, 75015 Paris, France.
Förderung
- University Research Committee, Emory University
- Federation Francaise de Cardiologie
Zitieren
APA
Sudaka, A., Thambo, J. B., Vaksmann, G., Hadeed, K., Houeijeh, A., Khraiche, D., Hery, E., Vincenti, M., Pangaud, N., Benbrik, N., Vastel, C., Legendre, A., Jalal, Z., Laux, D., Harchaoui, S., Lambert, V., Chalard, A., Douchin, S., Bouzguenda, I., …, & FRANCISCO investigators (2025). Anatomical insights and management strategies for haemodynamically significant pressure-restrictive perimembranous ventricular septal defects: Findings from the French nationwide FRANCISCO cohort. Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2025.02.014
Vancouver
Sudaka A, Thambo JB, Vaksmann G, Hadeed K, Houeijeh A, Khraiche D, et al. Anatomical insights and management strategies for haemodynamically significant pressure-restrictive perimembranous ventricular septal defects: Findings from the French nationwide FRANCISCO cohort. Archives of Cardiovascular Diseases. 2025. doi:10.1016/j.acvd.2025.02.014
BibTeX
@article{Sudaka2025,
author = {Sudaka, Annabel and Thambo, Jean-Benoit and Vaksmann, Guy and Hadeed, Khaled and Houeijeh, Ali and Khraiche, Diala and Hery, Eric and Vincenti, Marie and Pangaud, Nicolas and Benbrik, Nadir and Vastel, Carine and Legendre, Antoine and Jalal, Zakaria and Laux, Daniela and Harchaoui, Samir and Lambert, Virginie and Chalard, Aurélie and Douchin, Stéphanie and Bouzguenda, Ivan and Denis, Charlotte and Urbina-Hiel, Bérangère and Bonnemains, Laurent and Mostefa-Kara, Meriem and Ansquer, Hélène and Léty, Sophie and Leborgne, Anne-Sophie and Cohen, Laurence and Lupoglazoff, Jean Marc and Guirgis, Maurice and Maragnes, Pascale and Moceri, Pamela and Bertail, Claire and Lefort, Bruno and Ovaert, Caroline and Haddad, Raymond N and Guirgis, Lisa and Hascoet, Sébastien and FRANCISCO investigators, FRANCISCO investigators},
title = {Anatomical insights and management strategies for haemodynamically significant pressure-restrictive perimembranous ventricular septal defects: Findings from the French nationwide FRANCISCO cohort},
journal = {Archives of Cardiovascular Diseases},
year = {2025},
doi = {10.1016/j.acvd.2025.02.014}
}
EUVIMED